FILTER

FILTERED INTERVIEW RESULTS

Bindi Chudgar

MANAGING DIRECTOR, LAMBDA THERAPEUTIC RESEARCH
"With our expanding global footprint, we firmly believe that we are well positioned to achieve the vision of creating benchmarks and shaping the future of the clinical research industry by ensuring quality, reliability, and value-added services.”

Karan Singh

MANAGING DIRECTOR, ACG
"Personalized medicine will disrupt the pharma industry. I also see more people looking to leverage the digitization of patient care, such as through telemedicine or the creation of wearable technologies."

Dr. Hemant Koshia

COMMISSIONER, FDCA (FOOD AND DRUG CONTROL ADMINISTRATION) GUJARAT
"In addition to pharmacy graduates, the pharmaceutical industry requires support from other industries like chemicals and petrochemicals, as well as top quality pharmacy machinery manufacturers. In Gujarat, we have all of this."

Mohal Sarabhai

CEO, ASENCE PHARMA PRIVATE LIMITED
"We are working closely with our US partners to bring one of the most affordable point of care testing (POCT) devices to the market that will be saliva-based to provide the accuracy of a PCR machine on a POC device."

Sudheendra Kulkarni

CEO, SOUTH ASIA & ASEAN FERRING PHARMACEUTICALS
Ferring is a global biopharmaceutical company based in Switzerland that has one of the most comprehensive footprints in India.

Milind Antani and Darren Punnen

LEAD - PHARMA, HEALTHCARE, MEDICAL SERVICE AND DIGITAL HEALTH PRACTICE & LEADER - PHARMA AND LIFE SCIENCES PRACTICE, NISHITH DESAI ASSOCIATES (NDA)
Practice, Nishith Desai Associates (NDA) speak about legal developments relating to India’s life sciences industry

Peter DeYoung

CEO, PIRAMAL
Piramal Pharma updates GBR in its recent developments and prospects.

Lakshmi Prasanna Chundu

DIRECTOR - REGULATORY AFFAIRS, THE PHARMACEUTICAL EXPORT PROMOTION COUNCIL OF INDIA (PHARMEXCIL)
Pharmexcil explains how the agency is promoting India’s life sciences exports, which aim to reach US$40 billion in five years.

Daara Patel

SECRETARY GENERAL, INDIAN DRUG MANUFACTURERS’ ASSOCIATION (IDMA)
"Today, India's pharmaceutical sector is a US$50 billion industry and we anticipate it growing to at least US$150 billion in less than a decade."

Jeff Luber

CEO, BINX HEALTH, INC.
"Certainly, the way healthcare is consumed has changed forever with people looking for convenient on-site and at-home solutions for care and we see this accelerating."

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

Québec and Atlantic Canada Mining 2025

Québec and Atlantic Canada have traversed 2025 in an enviable position. Strong gold prices have buoyed balance sheets and investor sentiment, while global demand for critical minerals keeps the region firmly on the radar of international markets. At the same time, the provinces’ depth of mining expertise – from AI-driven exploration to advanced drilling, blasting, and geophysics – ensures that technological advantage is firmly on their side.

PARTNER EVENTS